A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion

Clinical trial NCT06820749 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06820749
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma Bronchiale Bronchiectasis Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2024-12-10
Primary completion: 2026-04-23
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.